Trump Seeks Totally Independent Fed Chair Pressured Predecessor on Rates Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting It with Bed Bath Beyond Great Britain Retail Sales Fall 13 in April as Fuel Purchases See Sharpest Drop Since Pandemic Diversified Energy Expands Permian Footprint With Maverick Natural Resources Acquisition Helios Underwriting Schedules June 22 Annual General Meeting Confirms Dividend Payment Dates Constellation CEG Commences Operations at Pin Oak Energy Facility Bolstering Generation Capacity RYDE Q2 2025 Earnings EPS Misses Estimates Shares Surge 947 Fluent Inc FLNT Q1 2026 Earnings EPS Beats Estimates Narrowly as Revenue Remains Unreported REPL Q1 2026 Earnings Narrower Than Expected Loss but Revenue Remains Elusive Disc Medicine Q1 2026 Earnings NarrowerThanExpected Loss Offsets Lack of Revenue Stock Edges Down OCFC Q1 2026 Earnings Earnings Per Share Surpasses Expectations Shares Edge Higher DFLI Q1 2026 Earnings WiderthanExpected Loss Reflects Continued RD Investment AtlasClear Holdings ATCH Hovers Near Support Amid Mild Selling Greenlight Capital Re Ltd GLRE Faces Selling Pressure as Shares Decline 256 Diversified Healthcare Trust DHC Edges Lower as Support Levels Come into Focus Starfighters Space Inc FJET Ascends 188 Testing Resistance at 710 indie Semiconductor Surges 15 as Momentum Builds Key Levels to Watch Microsoft Appoints New Trusted Technology Head to Balance AI Speed with Responsible Development PSQH Q1 2026 Earnings Narrowed Loss Exceeds Analyst Estimates American Outdoor Brands AOUT Holds Steady Near Key Support After Marginal Gain Palvella Therapeutics PVLA Slips 166 as Shares Test Key Support Levels BitMine Immersion Technologies BMNR Eases as Stock Tests Key Support After 1 Decline Presidio Property Trust Preferred Stock SQFTP Edges Higher Amid Steady Trading Global Business Travel Group GBTG Holds Steady at 944 Amidst Consolidation First United Corporation FUNC Slips 107 as Stock Tests Key Support Levels FIGX Capital Acquisition Corp Warrants FIGXW Hold Steady at 020 Key Levels in Focus Cartesian Therapeutics RNAC Gains 46 as Biotech Sector Shows Renewed Interest